An update on core needle biopsy for radiologically detected breast lesions

Abstract

BACKGROUND.Traditionally, radiologically detected lesions of the breast have been

Imaging–histologic discordance at percutaneous breast biopsy

“…[23][24][25][26] In subsequent clinical studies, the frequency of missed carcinomas at large-core needle biopsy averaged 2.9% (range, 0.3-8.2%), with approximately 75% of these missed carcinomas identified shortly after biopsy ("immediate false negatives") and 25% identified later ("delayed false negatives"). 5,6,[27][28][29][30][31][32][33] Missed carcinomas may result from inaccurate needle placement, poor tissue acquisition, or sampling error. 6 Imaging-histologic correlation may enable prospective identification of a missed cancer, averting delay in diagnosis.…”

A prospective comparison of stereotaxic fine‐needle aspiration versus stereotaxic core needle biopsy for the diagnosis of mammographic abnormalities

“…[12][13][14][15][16] With greater acceptance of these techniques, studies with clinical and mammographic follow-up of negative cases were reported following SFNA 3,[17][18][19][20][21] or SCBX. [22][23][24][25][26][27][28][29][30] These latter studies more accurately represent current clinical practice, reflecting the widespread use of these techniques in both community and academic medical centers.…”

Extent of Lumpectomy for Breast Cancer After Diagnosis by Stereotactic Core Versus Wire Localization Biopsy

“…Several reports have documented these lesions to be cancers in approximately 80% of cases. 9 The role of stereotactic core biopsy has been controversial in this category of patients. Because of the high index of suspicion of these lesions, some clinicians recommend an open biopsy to obtain a definitive diagnosis, because a nondiagnostic reading of a stereotactic core biopsy would not avoid the need for a subsequent open biopsy.…”

“…It costs less than a surgical biopsy [5][6][7] and has been reported to have a high sensitivity and specificity rate in diagnosis. 8,9 However, there are some difficulties in differentiating between atypical ductal hyperplasia and breast carcinoma.…”